Professor Zoe Winters - Breast Cancer Consultant & Breast Specialist

20/02/2026

- Drugs called Cyclin dependent Kinase inhibitors (CDKIs) are currently used with endocrine treatments that block ER+ breast cancers.

In more advanced breast cancers that are HER2 positive, CDKIs double the length of *progression free survival when combined with aromatase inhibitors (Letrozole).

(Progression-Free Survival (PFS) is the length of time during and after treatment that a patient lives with a disease (usually cancer) without it getting worse or spreading).

For paper - https://pubmed.ncbi.nlm.nih.gov/41604639/



Photo RM Photography

17/02/2026

Very important subject.

17/02/2026

- AI fun.. As we appear to be shifting, from experimentation to integration of AI, here's what AI generated for me. I love it.. 😀

13/02/2026

Consolidating 10 years of adjuvant Aromatase Inhibitor Treatment (AIT) significantly reduces risks of breast cancer recurrences (both local and distant).

These benefits also occur with 5 years of upfront Tamoxifen, followed by 5 years of AIT.

However, women need to discuss their bone health and quality of life with their Oncologist and Surgeon.

Early Breast Cancer Trialists Collaborative Group, Lancet 2025

Link to paper: https://pubmed.ncbi.nlm.nih.gov/40783288/

🎀🎗

Cancer Research UK and Breast Cancer Research Foundation.

04/02/2026

A message from a very courageous patient.

Empowering women with the latest knowledge is fundamental in helping them to make informed decisions.

With a strong family history in cancer, Sinead chose a path of prevention.

What an amazing job Sinead is doing to help others and keeping fit. Power on 👏💪😍

“Zoe’s support last year was instrumental in supporting me to make my decision to have surgery, but to stay fit in the meantime. So I kept myself busy doing fundraising for Breast Cancer UK

I’m still waiting on surgery, but know with knowledge she supported me with, it was the right one”

04/02/2026

- Key modifiable factors linked to higher rates of developing breast cancer are:

5. Evidenced based risk factors for Breast Cancer

04/02/2026

04/02/2026

03/02/2026

- Key modifiable factors linked to higher rates of developing breast cancer are:

4. Breast Density

02/02/2026

- Key modifiable factors linked to higher rates of developing breast cancer are:

3. Alcohol

30/01/2026

- Key modifiable factors linked to higher rates of developing breast cancer are:

2. Physical exercise